What are the major opportunities in the Guillain-Barre Syndrome Drugs market? What are the strategies for the Guillain-Barre Syndrome Drugs market?

For detailed insights on the major opportunities and strategies in the Guillain-Barre Syndrome Drugs market, Read More

How does the Guillain-Barre Syndrome Drugs market relate to the overall economy and other similar markets?

For detailed insights on Guillain-Barre Syndrome Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Guillain-Barre Syndrome Drugs market growth? SWOT analysis of the Guillain-Barre Syndrome Drugs market.

For detailed insights on the key dynamics influencing the Guillain-Barre Syndrome Drugs market growth and SWOT analysis of the Guillain-Barre Syndrome Drugs industry, Read More

Guillain-Barre Syndrome Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Guillain-Barre Syndrome Drugs Market Report 2026

Name: Guillain-Barre Syndrome Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Immunoglobulins (IVIG), Corticosteroids, Plasma Exchange), By Treatment Type (First-Line Treatment, Adjunctive Or Supportive Treatment), By Application (Clinic, Hospital, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Guillain-Barre Syndrome Drugs Market Overview

• Guillain-Barre Syndrome Drugs market size has reached to $1.25 billion in 2025

• Expected to grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Personalized Medicine Drives Guillain-Barre Syndrome Drugs Market Growth

• Market Trend: Innovative Humanized Monoclonal Antibodies Revolutionize Guillain-Barre Syndrome Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Guillain-Barre Syndrome Drugs Market?

Guillain-Barre syndrome drugs refer to medications administered to manage the symptoms and complications of Guillain-Barre syndrome (GBS), an autoimmune disorder characterized by the immune system attacking the nervous system. These drugs are primarily aimed at modulating the peripheral immune system's activity to halt the progression of the disease and manage its symptoms.

The main types of guillain-barre syndrome drug classes include immunoglobulins (IVIG), corticosteroids, and plasma exchange. Intravenous immunoglobulin (IVIG) is a medication made from pooled human blood plasma that contains a high concentration of antibodies. They are used in first-line treatment and adjunctive or supportive treatments and find several applications in clinics, hospitals, and others.

Guillain-Barre Syndrome Drugs Market Global Report 2026 Market Report bar graph

What Is The Guillain-Barre Syndrome Drugs Market Size and Share 2026?

The guillain-barre syndrome drugs market size has grown strongly in recent years. It will grow from $1.25 billion in 2025 to $1.35 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to established clinical effectiveness of ivig therapy, long-standing use of plasma exchange in neurological disorders, availability of corticosteroids for symptom management, expansion of hospital neurology departments, increased recognition of gbs as a medical emergency.

What Is The Guillain-Barre Syndrome Drugs Market Growth Forecast?

The guillain-barre syndrome drugs market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising incidence of autoimmune neurological disorders, growing awareness of post-infectious gbs cases, increasing access to advanced hospital care, expansion of ivig manufacturing capacity, demand for rapid immune-modulating therapies in acute care. Major trends in the forecast period include continued reliance on intravenous immunoglobulin as first-line therapy, rising use of plasma exchange in severe guillain-barre cases, growing emphasis on early diagnosis and rapid treatment initiation, increasing demand for hospital-based intensive gbs management, steady use of supportive and adjunctive drug therapies.

Book your 30 minutes free consultation with our research experts

Global Guillain-Barre Syndrome Drugs Market Segmentation

1) By Drug Class: Immunoglobulins (IVIG), Corticosteroids, Plasma Exchange

2) By Treatment Type: First-Line Treatment, Adjunctive Or Supportive Treatment

3) By Application: Clinic, Hospital, Other Applications

Subsegments:

1) By Immunoglobulins (Ivig): Intravenous Immunoglobulin (Ivig) Therapy, Human Normal Immunoglobulin (Hnig), Hyperimmune Immunoglobulin Products, Ivig Formulations For GBS Treatment

2) By Corticosteroids: Methylprednisolone, Prednisolone, Dexamethasone, Hydrocortisone, Betamethasone

3) By Plasma Exchange: Therapeutic Plasma Exchange (TPE), Plasmapheresis

What Are The Drivers Of The Guillain-Barre Syndrome Drugs Market?

The growing demand for personalized medicine is expected to propel the growth of the Guillain-Barré syndrome drugs market going forward. Personalized medicine refers to the customization of medical treatment based on an individual’s genetic makeup, biomarkers, or lifestyle factors to enhance therapeutic effectiveness and reduce adverse effects. The demand for personalized medicine is increasing due to advancements in genomics, rising disease complexity, improved diagnostic technologies, and strong regulatory support. The Guillain-Barré syndrome drugs market benefits from personalized medicine by enabling tailored treatment approaches that improve patient outcomes and reduce complications associated with generalized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the U.S. Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six therapies in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the Guillain-Barré syndrome drugs market.

The increasing prevalence of autoimmune disorders is expected to propel the growth of the Guillain-Barré syndrome drugs market going forward. Autoimmune disorders refer to conditions in which the immune system mistakenly attacks the body's own healthy cells and tissues, leading to inflammation and tissue damage. The increasing prevalence of autoimmune disorders is primarily due to a genetic predisposition, meaning that individuals inherit certain genes that make their immune system more likely to mistakenly attack the body’s own tissues. Guillain-Barré syndrome drugs support autoimmune disorders by modulating the immune system to reduce abnormal antibody-mediated attacks on peripheral nerves, thereby alleviating symptoms and preventing disease progression. For instance, in February 2024, according to Arthritis Australia, an Australia-based non-profit organization, In 2025, an estimated 212,136 males and 362,137 females are projected to have rheumatoid arthritis (RA), with the numbers expected to rise by 2040 to approximately 280,040 males and 479,828 females. Therefore, the increasing prevalence of autoimmune disorders is driving the growth of the Guillain-Barré syndrome drugs market.

Key Players In The Global Guillain-Barre Syndrome Drugs Market

Major companies operating in the guillain-barre syndrome drugs market are CSL Behring LLC, Grifols SA, Octapharma AG, Takeda Pharmaceutical Company Limited, Biotest AG, Kedrion Biopharma Inc., Alexion Pharmaceuticals Inc., Argenx SE, Annexon Inc., Hansa Medical AB, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie Inc., Biogen Inc., Chugai Pharmaceutical Co. Ltd., Cadila Healthcare Limited, Akari Therapeutics Plc, Cellenkos Inc., Regenesance BV, Cresence AS

Global Guillain-Barre Syndrome Drugs Market Trends and Insights

Major companies operating in the Guillain-Barré syndrome (GBS) drugs market are focusing on developing innovative products such as humanized monoclonal antibodies to enhance therapeutic precision, reduce immune-mediated nerve damage, and strengthen their competitive position. A humanized monoclonal antibody refers to a laboratory-engineered antibody composed primarily of human antibody sequences with a small portion derived from mouse or rat monoclonal antibodies, designed to target specific immune components involved in GBS pathology and limit complement-mediated inflammation. For instance, in October 2023, Annexon Inc., a US-based clinical-stage biopharmaceutical company, announced that both the European Medicines Agency and the U.S. Food and Drug Administration had granted orphan drug designation to ANX005, a humanized monoclonal antibody that selectively inhibits C1q to prevent complement-driven neuronal injury in GBS. The company also reported completing target enrollment for its Phase 3 trial, with topline results expected in the first half of 2024, highlighting ANX005’s potential to rapidly halt autoimmune damage and support muscle strength recovery in affected patients.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the guillain-barre syndrome drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Guillain-Barre Syndrome Drugs Market?

The guillain-barre syndrome drugs market consists of sales of monoclonal antibodies, cell therapies, and recombinant enzymes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Guillain-Barre Syndrome Drugs Market Report 2026?

The guillain-barre syndrome drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the guillain-barre syndrome drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Guillain-Barre Syndrome Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$1.35 billion
Revenue Forecast In 2035	$1.73 billion
Growth Rate	CAGR of 7.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Treatment Type, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	CSL Behring LLC, Grifols SA, Octapharma AG, Takeda Pharmaceutical Company Limited, Biotest AG, Kedrion Biopharma Inc., Alexion Pharmaceuticals Inc., Argenx SE, Annexon Inc., Hansa Medical AB, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie Inc., Biogen In
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Guillain-Barre Syndrome Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Guillain-Barre Syndrome Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Guillain-Barre Syndrome Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Guillain-Barre Syndrome Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Continued Reliance On Intravenous Immunoglobulin As First-Line Therapy

4.2.2 Rising Use Of Plasma Exchange In Severe Guillain-Barre Cases

4.2.3 Growing Emphasis On Early Diagnosis And Rapid Treatment Initiation

4.2.4 Increasing Demand For Hospital-Based Intensive Gbs Management

4.2.5 Steady Use Of Supportive And Adjunctive Drug Therapies

5. Guillain-Barre Syndrome Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Neurology Clinics

5.3 Intensive Care Units

5.4 Specialty Neurological Centers

5.5 Rehabilitation Centers

6. Guillain-Barre Syndrome Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Guillain-Barre Syndrome Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Guillain-Barre Syndrome Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Guillain-Barre Syndrome Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Guillain-Barre Syndrome Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Guillain-Barre Syndrome Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Guillain-Barre Syndrome Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Guillain-Barre Syndrome Drugs Market Segmentation

9.1. Global Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoglobulins (IVIG), Corticosteroids, Plasma Exchange

9.2. Global Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

First-Line Treatment, Adjunctive Or Supportive Treatment

9.3. Global Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinic, Hospital, Other Applications

9.4. Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Immunoglobulins (IVIG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous Immunoglobulin (IVIG) Therapy, Human Normal Immunoglobulin (HNIG), Hyperimmune Immunoglobulin Products, IVIG Formulations For GBS Treatment

9.5. Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Methylprednisolone, Prednisolone, Dexamethasone, Hydrocortisone, Betamethasone

9.6. Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Plasma Exchange, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Therapeutic Plasma Exchange (TPE), Plasmapheresis

10. Guillain-Barre Syndrome Drugs Market Regional And Country Analysis

10.1. Global Guillain-Barre Syndrome Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Guillain-Barre Syndrome Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Guillain-Barre Syndrome Drugs Market

11.1. Asia-Pacific Guillain-Barre Syndrome Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Guillain-Barre Syndrome Drugs Market

12.1. China Guillain-Barre Syndrome Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Guillain-Barre Syndrome Drugs Market

13.1. India Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Guillain-Barre Syndrome Drugs Market

14.1. Japan Guillain-Barre Syndrome Drugs Market Overview

14.2. Japan Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Guillain-Barre Syndrome Drugs Market

15.1. Australia Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Guillain-Barre Syndrome Drugs Market

16.1. Indonesia Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Guillain-Barre Syndrome Drugs Market

17.1. South Korea Guillain-Barre Syndrome Drugs Market Overview

17.2. South Korea Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Guillain-Barre Syndrome Drugs Market

18.1. Taiwan Guillain-Barre Syndrome Drugs Market Overview

18.2. Taiwan Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Guillain-Barre Syndrome Drugs Market

19.1. South East Asia Guillain-Barre Syndrome Drugs Market Overview

19.2. South East Asia Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Guillain-Barre Syndrome Drugs Market

20.1. Western Europe Guillain-Barre Syndrome Drugs Market Overview

20.2. Western Europe Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Guillain-Barre Syndrome Drugs Market

21.1. UK Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Guillain-Barre Syndrome Drugs Market

22.1. Germany Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Guillain-Barre Syndrome Drugs Market

23.1. France Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Guillain-Barre Syndrome Drugs Market

24.1. Italy Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Guillain-Barre Syndrome Drugs Market

25.1. Spain Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Guillain-Barre Syndrome Drugs Market

26.1. Eastern Europe Guillain-Barre Syndrome Drugs Market Overview

26.2. Eastern Europe Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Guillain-Barre Syndrome Drugs Market

27.1. Russia Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Guillain-Barre Syndrome Drugs Market

28.1. North America Guillain-Barre Syndrome Drugs Market Overview

28.2. North America Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Guillain-Barre Syndrome Drugs Market

29.1. USA Guillain-Barre Syndrome Drugs Market Overview

29.2. USA Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Guillain-Barre Syndrome Drugs Market

30.1. Canada Guillain-Barre Syndrome Drugs Market Overview

30.2. Canada Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Guillain-Barre Syndrome Drugs Market

31.1. South America Guillain-Barre Syndrome Drugs Market Overview

31.2. South America Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Guillain-Barre Syndrome Drugs Market

32.1. Brazil Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Guillain-Barre Syndrome Drugs Market

33.1. Middle East Guillain-Barre Syndrome Drugs Market Overview

33.2. Middle East Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Guillain-Barre Syndrome Drugs Market

34.1. Africa Guillain-Barre Syndrome Drugs Market Overview

34.2. Africa Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Segmentation By Treatment Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Guillain-Barre Syndrome Drugs Market Regulatory and Investment Landscape

36. Guillain-Barre Syndrome Drugs Market Competitive Landscape And Company Profiles

36.1. Guillain-Barre Syndrome Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Guillain-Barre Syndrome Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Guillain-Barre Syndrome Drugs Market Company Profiles

36.3.1. CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Grifols SA Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Biotest AG Overview, Products and Services, Strategy and Financial Analysis

37. Guillain-Barre Syndrome Drugs Market Other Major And Innovative Companies

Kedrion Biopharma Inc., Alexion Pharmaceuticals Inc., Argenx SE, Annexon Inc., Hansa Medical AB, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie Inc., Biogen Inc., Chugai Pharmaceutical Co. Ltd., Cadila Healthcare Limited, Akari Therapeutics Plc, Cellenkos Inc., Regenesance BV, Cresence AS

38. Global Guillain-Barre Syndrome Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Guillain-Barre Syndrome Drugs Market

40. Guillain-Barre Syndrome Drugs Market High Potential Countries, Segments and Strategies

40.1 Guillain-Barre Syndrome Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Guillain-Barre Syndrome Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Guillain-Barre Syndrome Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Guillain-Barre Syndrome Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Guillain-Barre Syndrome Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Guillain-Barre Syndrome Drugs Market, Supply Chain Analysis

Table 4: Global Guillain-Barre Syndrome Drugs Market, Major Raw Material Providers

Table 5: Global Guillain-Barre Syndrome Drugs Market, Major Resource Providers

Table 6: Global Guillain-Barre Syndrome Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Guillain-Barre Syndrome Drugs Market, Major Distributors And Channel Partners

Table 8: Global Guillain-Barre Syndrome Drugs Market, Key Technologies & Future Trends

Table 9: Global Guillain-Barre Syndrome Drugs Market, Major Trends

Table 10: Global Guillain-Barre Syndrome Drugs Market, Major End Users

Table 11: Global Guillain-Barre Syndrome Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Guillain-Barre Syndrome Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Guillain-Barre Syndrome Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Guillain-Barre Syndrome Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Immunoglobulins (IVIG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Plasma Exchange, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Guillain-Barre Syndrome Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Guillain-Barre Syndrome Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Guillain-Barre Syndrome Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Guillain-Barre Syndrome Drugs Market - Company Scoring Matrix

Table 97: CSL Behring LLC Financial Performance

Table 98: Grifols SA Financial Performance

Table 99: Octapharma AG Financial Performance

Table 100: Takeda Pharmaceutical Company Limited Financial Performance

Table 101: Biotest AG Financial Performance

Table 102: Global Guillain-Barre Syndrome Drugs Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Guillain-Barre Syndrome Drugs Market, Competitive Dashboard

Table 104: Global Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 106: Global, Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 107: Global, Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Guillain-Barre Syndrome Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Guillain-Barre Syndrome Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Guillain-Barre Syndrome Drugs Market, Supply Chain Analysis

Figure 4: Global Guillain-Barre Syndrome Drugs Market, Major Raw Material Providers

Figure 5: Global Guillain-Barre Syndrome Drugs Market, Major Resource Providers

Figure 6: Global Guillain-Barre Syndrome Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Guillain-Barre Syndrome Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Guillain-Barre Syndrome Drugs Market, Key Technologies & Future Trends

Figure 9: Global Guillain-Barre Syndrome Drugs Market, Major Trends

Figure 10: Global Guillain-Barre Syndrome Drugs Market, Major End Users

Figure 11: Global Guillain-Barre Syndrome Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Guillain-Barre Syndrome Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Guillain-Barre Syndrome Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Guillain-Barre Syndrome Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Immunoglobulins (IVIG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Guillain-Barre Syndrome Drugs Market, Sub-Segmentation Of Plasma Exchange, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Guillain-Barre Syndrome Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Guillain-Barre Syndrome Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Guillain-Barre Syndrome Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Guillain-Barre Syndrome Drugs Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Guillain-Barre Syndrome Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Guillain-Barre Syndrome Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Guillain-Barre Syndrome Drugs Market - Company Scoring Matrix

Figure 97: CSL Behring LLC Financial Performance

Figure 98: Grifols SA Financial Performance

Figure 99: Octapharma AG Financial Performance

Figure 100: Takeda Pharmaceutical Company Limited Financial Performance

Figure 101: Biotest AG Financial Performance

Figure 102: Global Guillain-Barre Syndrome Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Guillain-Barre Syndrome Drugs Market, Competitive Dashboard

Figure 104: Global Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 106: Global, Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 107: Global, Guillain-Barre Syndrome Drugs Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Cold And Flu Supplements Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Cold Remedies Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Cold, Cough, And Sore Throat Remedies Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Cold, Cough, And Sore Throat Remedies Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Terminal Tractor Market Report 2026 - Global Outlook – By Type (Manual, Automated), By Propulsion (Diesel, Compressed Natural Gas (CNG), Hybrid, Electric), By Tonnage (Less Than 50 Ton, 50-100 Ton, Greater Than 100 Ton),...

Glass Substrate Market Report 2026 - Global Outlook – By Type (Borosilicate Based, Fused Silica And Quartz Based, Other Types), By Wafer Diameter (300 mm, 200 mm, 150 mm, 125 mm, Above 300 mm, Upto 100 mm), By Applicatio...

Pharmaceutical Suppositories Market Report 2026 - Global Outlook – By Type (Rectal Suppositories, Vaginal Suppositories, Urethral Suppositories, Other Types), By Base (Fatty Base, Water Miscible Bases, Emulsifying Bases)...

Flexion Tires Market Report 2026 - Global Outlook – By Technology Type (Very High Flexion (VF) Tires, Increased Flexion (IF) Tires), By Construction Type (Radial Flexion Tires, Bias (Cross-Ply) Flexion Tires), By Applica...

Onshore Wind Turbine Market Report 2026 - Global Outlook – By Axis (Horizontal Axis, Vertical Axis), By Size (Small Scale, Medium Scale, Large Scale), By Technology (Electrically Excited Synchronous Generator, Permanent ...

Frequently Asked Questions

How big is the Guillain-Barre Syndrome Drugs Market?

The Guillain-Barre Syndrome Drugs market was valued at $1.25 billion in 2025, increased to $1.35 billion in 2026, and is projected to reach $1.73 billion by 2030.

What is the Guillain-Barre Syndrome Drugs market growth?

The global Guillain-Barre Syndrome Drugs market is expected to grow at a CAGR of 6.5% from 2026 to 2035 to reach $1.73 billion by 2035.

Who are the key players in Guillain-Barre Syndrome Drugs market?

Some Key Players in the Guillain-Barre Syndrome Drugs market Include, CSL Behring LLC, Grifols SA, Octapharma AG, Takeda Pharmaceutical Company Limited, Biotest AG, Kedrion Biopharma Inc., Alexion Pharmaceuticals Inc., Argenx SE, Annexon Inc., Hansa M

Major trend in this market includes: Innovative Humanized Monoclonal Antibodies Revolutionize Guillain-Barre Syndrome Treatment. For further insights on this market. request a sample here

North America was the largest region in the guillain-barre syndrome drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the guillain-barre syndrome drugs market repor

Book your 30 minutes free consultation with our research experts

Contact Us